6/4/24 17:57 | 6/3/24 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Spiegelman Daniel K | UT | D | | S.m | -167 | 22.05 | 0 | -8 | -19 | 33 | D | | | | | | | | | | | | | | |
6/2/23 18:15 | 6/2/23 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Spiegelman Daniel K | UT | D | | S | -199 | 23.01 | 0 | -9 | -18 | 40 | D | | | | | | | | | | | | | | |
6/6/22 19:20 | 6/6/22 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Spiegelman Daniel K | UT | D | | S | -124 | 19.25 | 0 | -6 | -16 | 34 | D | | | | | | | | | | | | | | |
6/17/21 17:41 | 6/17/21 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Spiegelman Daniel K | UT | D | | S | -96 | 30.52 | 0 | -3 | -12 | 23 | D | | | | | | | | | | | | | | |
6/1/21 19:15 | 5/28/21 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Spiegelman Daniel K | UT | D | | S | -207 | 28.99 | 0 | -7 | -35 | 13 | D | | | | | | | | | | | | | | |
4/3/19 13:17 | 4/1/19 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S | -1,199 | 89.00 | 0 | -13 | -22 | 48 | D | | | | | | | | | | | | | | |
3/29/19 18:19 | 3/27/19 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S | -9 | 90.00 | 0 | 0 | 0 | 61 | D | | | | | | | | | | | | | | |
6/26/18 20:31 | 6/22/18 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S | -990 | 99.00 | 0 | -10 | -16 | 51 | D | | | | | | | | | | | | | | |
4/25/18 20:37 | 4/23/18 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S | -908 | 82.15 | 0 | -11 | -15 | 63 | D | | | | | | | | | | | | | | |
10/13/17 20:43 | 5/27/15 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | M.ad | 2,311 | 67.81 | 0 | 34 | 82 | 76 | D | | | | | | | | | | | | | | |
10/13/17 20:43 | 5/27/15 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S.ad | -4,430 | 130.00 | 0 | -34 | -31 | 76 | D | | | | | | | | | | | | | | |
9/26/17 17:22 | 9/24/17 | CASC | Cascadian Therapeutics, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Spiegelman Daniel K | WA | D | | M.d | 0 | 0.00 | 0 | 2 | 13 | 21 | D | | | | | | | | | | | | | | |
6/27/17 17:41 | 6/24/17 | CASC | Cascadian Therapeutics, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Spiegelman Daniel K | WA | D | | M.d | 0 | 0.00 | 0 | 9 | 89 | 19 | D | | | | | | | | | | | | | | |
6/13/17 16:42 | 6/12/17 | CASC | Cascadian Therapeutics, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Spiegelman Daniel K | WA | D | | M.d | 0 | 0.00 | 0 | 2 | 21 | 12 | D | | | | | | | | | | | | | | |
3/17/17 18:30 | 3/16/17 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S | -183 | 91.96 | 33 | -2 | -12 | 14 | D | -29 | 13 | -5 | 9 | 3 | 4 | 2 | -2 | -1 | -4 | 0 | | | |
3/8/17 19:28 | 3/6/17 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S | -215 | 93.32 | 33 | -2 | -10 | 21 | D | -22 | 1 | -7 | 9 | 6 | -2 | 2 | -4 | 1 | 1 | -5 | | | |
3/2/17 18:20 | 2/28/17 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | M.d | 1,893 | 63.10 | 33 | 30 | | 25 | D | -13 | 7 | -2 | 6 | 8 | 3 | 4 | 7 | 1 | -3 | -5 | | | |
3/2/17 18:20 | 2/28/17 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S.dm | -3,293 | 94.07 | 33 | -35 | -58 | 25 | D | -13 | 7 | -2 | 6 | 8 | 3 | 4 | 7 | 1 | -3 | -5 | | | |
1/10/17 16:50 | 1/9/17 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S | -450 | 90.00 | 33 | -5 | -22 | 18 | D | -3 | -5 | 3 | -3 | 2 | 7 | 8 | 5 | -5 | -6 | 1 | -2 | | |
11/14/16 14:02 | 11/9/16 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S | -1,812 | 90.61 | 33 | -20 | -46 | 23 | D | 5 | -14 | 6 | -2 | -3 | 11 | 13 | 10 | 2 | -3 | -9 | 0 | | |
8/3/16 10:19 | 8/1/16 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S | -397 | 99.33 | 33 | -4 | -9 | 43 | D | 60 | -33 | 38 | 16 | 22 | 14 | 6 | 1 | 2 | -4 | -5 | -19 | -11 | |
6/8/16 20:39 | 6/6/16 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S | -147 | 89.14 | 33 | -2 | -3 | 47 | D | 38 | -31 | -13 | 0 | -4 | 2 | -2 | -7 | -1 | -4 | 5 | 13 | -2 | |
6/8/16 17:22 | 6/7/16 | RLYP | Relypsa Inc | | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | D | | S | -20 | 19.31 | 33 | -1 | -45 | 1 | D | -21 | -46 | -34 | 43 | 5 | 32 | 17 | -7 | -2 | 1 | 2 | | | |
6/2/16 18:21 | 5/31/16 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | M.d | 660 | 39.06 | 33 | 17 | 50 | 50 | D | 51 | -30 | -8 | 0 | -2 | 6 | 1 | 0 | -2 | -8 | -16 | 4 | -5 | |
6/2/16 18:21 | 5/31/16 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S.d | -1,873 | 89.88 | 33 | -21 | -29 | 50 | D | 51 | -30 | -8 | 0 | -2 | 6 | 1 | 0 | -2 | -8 | -16 | 4 | -5 | |
5/25/16 14:57 | 5/23/16 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S | -328 | 87.07 | 33 | -4 | -6 | 59 | D | 56 | -31 | -9 | 15 | -1 | 7 | 6 | 4 | 1 | -1 | -5 | 13 | -1 | |
3/2/16 20:37 | 3/2/16 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S | -398 | 86.12 | 33 | -5 | -9 | 50 | D | 8 | -19 | -34 | -9 | 10 | 34 | 13 | 15 | 2 | -2 | -6 | 3 | 9 | 7 |
11/18/15 16:03 | 11/16/15 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | M.d | 781 | 39.06 | 33 | 20 | 243 | 28 | D | 55 | 29 | -16 | -21 | 5 | -6 | -7 | 0 | -4 | -9 | -7 | -28 | -21 | -17 |
11/18/15 16:03 | 11/16/15 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S.d | -2,086 | 104.30 | 33 | -20 | -41 | 28 | D | 55 | 29 | -16 | -21 | 5 | -6 | -7 | 0 | -4 | -9 | -7 | -28 | -21 | -17 |
6/16/15 17:00 | 6/13/15 | ONTY | Oncothyreon Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Spiegelman Daniel K | WA | D | | M.d | 0 | 0.00 | 32 | 16 | 44 | 53 | D | 108 | 22 | 127 | 116 | 165 | 11 | -3 | -3 | 3 | 3 | -3 | -15 | -39 | |
6/8/15 18:09 | 6/5/15 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S | -202 | 122.30 | 33 | -2 | -6 | 28 | D | 115 | 96 | 36 | 9 | 3 | 1 | -4 | 0 | -3 | -2 | 13 | 2 | -24 | -28 |
6/3/15 20:27 | 5/29/15 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S.m | -689 | 124.73 | 33 | -6 | -15 | 32 | D | 98 | 114 | 38 | 14 | 2 | 2 | -2 | -3 | -3 | -3 | 10 | 4 | -23 | -29 |
5/28/15 17:10 | 5/18/15 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S | -4,430 | 130.00 | 33 | -34 | -45 | 42 | D | 101 | 127 | 51 | 21 | 7 | 8 | 6 | 2 | -1 | -3 | 6 | -5 | -23 | -30 |
5/19/15 19:25 | 5/18/15 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S | -257 | 124.77 | 33 | -2 | -3 | 76 | D | 95 | 119 | 43 | 24 | 4 | 9 | 5 | 4 | 2 | 2 | -1 | 11 | -14 | -32 |
4/2/15 17:11 | 3/25/15 | ONTY | Oncothyreon Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Spiegelman Daniel K | WA | D | | P.am | 32 | 1.61 | 2 | 20 | 97 | 41 | D | -26 | -49 | -17 | -18 | 3 | -11 | -5 | -3 | -2 | 2 | -11 | 123 | 68 | -26 |
4/1/15 19:28 | 3/25/15 | ONTY | Oncothyreon Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Spiegelman Daniel K | WA | D | | P.m | 32 | 1.61 | 2 | 20 | 97 | 41 | D | -26 | -45 | -21 | -15 | 4 | -3 | -5 | 1 | 3 | 3 | -6 | 131 | 72 | -20 |
3/4/15 19:48 | 3/2/15 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | M.d | 605 | 39.06 | 33 | 16 | 29 | 69 | D | 82 | 36 | 52 | 21 | 9 | 14 | 1 | 0 | 3 | 3 | 10 | 13 | 18 | -21 |
3/4/15 19:48 | 3/2/15 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S.d | -1,659 | 107.00 | 33 | -16 | -18 | 69 | D | 82 | 36 | 52 | 21 | 9 | 14 | 1 | 0 | 3 | 3 | 10 | 13 | 18 | -21 |
2/10/15 12:57 | 3/5/14 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S.m | -3 | 70.61 | 33 | 0 | 0 | 69 | D | 72 | 40 | 47 | 12 | 3 | -5 | -6 | 0 | 1 | 8 | 22 | 29 | 45 | -31 |
10/8/14 16:49 | 2/20/13 | ONTY | Oncothyreon Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Spiegelman Daniel K | WA | D | | S.m | -31 | 1.91 | 2 | -16 | -44 | 21 | D | -61 | 3 | -32 | -25 | -14 | 2 | -3 | -4 | -9 | -7 | -14 | -16 | -15 | 43 |
9/3/14 18:48 | 9/2/14 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | M.d | 625 | 39.06 | 33 | 16 | 30 | 69 | D | 84 | 8 | -13 | 14 | 17 | 9 | 1 | -1 | -3 | -3 | 0 | 28 | 56 | 77 |
9/3/14 18:48 | 9/2/14 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S.d | -1,117 | 69.83 | 33 | -16 | -19 | 69 | D | 84 | 8 | -13 | 14 | 17 | 9 | 1 | -1 | -3 | -3 | 0 | 28 | 56 | 77 |
8/4/14 16:35 | 8/1/14 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S | -138 | 61.76 | 33 | -2 | -3 | 69 | D | 57 | -4 | -10 | 7 | -6 | 5 | 0 | 2 | 1 | 0 | 10 | 29 | 50 | 134 |
7/3/14 15:24 | 7/2/14 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S | -143 | 64.00 | 33 | -2 | -3 | 71 | D | 71 | 8 | -9 | -6 | 14 | 4 | 0 | 2 | 0 | -8 | -4 | 10 | 41 | 113 |
3/12/14 17:04 | 3/11/14 | ONTY | Oncothyreon Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Spiegelman Daniel K | WA | D | | M.d | 0 | 0.00 | 3 | 19 | 99 | 39 | D | -30 | 64 | 97 | 87 | 70 | 26 | 18 | 4 | 5 | -9 | -15 | -13 | -43 | -56 |
3/5/14 16:40 | 3/3/14 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | M.d | 312 | 39.06 | 33 | 8 | 14 | 64 | D | 126 | 34 | 23 | 15 | 9 | 14 | -1 | -3 | -3 | -2 | -14 | -22 | -11 | 38 |
3/5/14 16:40 | 3/3/14 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S.d | -643 | 80.32 | 33 | -8 | -11 | 64 | D | 126 | 34 | 23 | 15 | 9 | 14 | -1 | -3 | -3 | -2 | -14 | -22 | -11 | 38 |
12/4/13 16:15 | 12/2/13 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | M.d | 352 | 39.06 | 33 | 9 | 31 | 38 | D | 102 | 44 | 21 | 1 | 4 | 13 | -1 | -1 | -1 | -1 | -1 | 10 | -10 | 30 |
12/4/13 16:15 | 12/2/13 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S.d | -631 | 70.14 | 33 | -9 | -19 | 38 | D | 102 | 44 | 21 | 1 | 4 | 13 | -1 | -1 | -1 | -1 | -1 | 10 | -10 | 30 |
9/5/13 18:51 | 9/4/13 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | M.d | 352 | 39.06 | 33 | 9 | 31 | 38 | D | 135 | 85 | 13 | 20 | 10 | 5 | 7 | 5 | 3 | 1 | 4 | -1 | 9 | -4 |
9/5/13 18:51 | 9/4/13 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S.d | -621 | 69.00 | 33 | -9 | -19 | 38 | D | 135 | 85 | 13 | 20 | 10 | 5 | 7 | 5 | 3 | 1 | 4 | -1 | 9 | -4 |
7/2/13 17:29 | 7/1/13 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S | -243 | 59.78 | 33 | -4 | -10 | 38 | D | 126 | 57 | 24 | -6 | -5 | 1 | 8 | 4 | -1 | 0 | 8 | 21 | 16 | 7 |
5/3/13 14:41 | 5/1/13 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | M.d | 1,094 | 39.06 | 33 | 28 | 560 | 33 | D | 145 | 90 | 69 | 20 | 10 | 2 | 1 | 2 | 1 | 1 | -9 | -2 | -3 | -12 |
5/3/13 14:41 | 5/1/13 | BMRN | Biomarin Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Spiegelman Daniel K | CA | O | EVP,CFO | S.d | -1,804 | 64.42 | 33 | -28 | -46 | 33 | D | 145 | 90 | 69 | 20 | 10 | 2 | 1 | 2 | 1 | 1 | -9 | -2 | -3 | -12 |
6/13/11 18:00 | 6/12/11 | ONTY | Oncothyreon Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Spiegelman Daniel K | WA | D | | M.d | 0 | 0.00 | 5 | 2 | 11 | 21 | D | 163 | 97 | 115 | 97 | 53 | 24 | 11 | 13 | 3 | 15 | 12 | 0 | 15 | -51 |
4/3/09 14:15 | 4/2/09 | CVTX | Cv Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Spiegelman Daniel K | CA | O | SVP,CFO | M.d | 2,221 | 11.75 | 0 | 189 | | 80 | D | | | | | | | | | | | | | | |
4/3/09 14:15 | 4/2/09 | CVTX | Cv Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Spiegelman Daniel K | CA | O | SVP,CFO | S.d | -2,808 | 19.91 | 0 | -141 | -64 | 80 | D | | | | | | | | | | | | | | |
2/26/09 15:23 | 2/25/09 | CVTX | Cv Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Spiegelman Daniel K | CA | O | SVP,CFO | M.d | 195 | 15.58 | 0 | 12 | 63 | 32 | B | | | | | | | | | | | | | | |
12/15/08 16:34 | 12/11/08 | CVTX | Cv Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Spiegelman Daniel K | CA | O | SVP,CFO | M.d | 42 | 8.48 | 0 | 5 | 27 | 24 | D | | | | | | | | | | | | | | |
12/10/08 17:49 | 12/9/08 | CVTX | Cv Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Spiegelman Daniel K | CA | O | SVP,CFO | M.d | 48 | 9.51 | 0 | 5 | 33 | 20 | D | | | | | | | | | | | | | | |
2/27/08 19:31 | 2/26/08 | CVTX | Cv Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Spiegelman Daniel K | CA | O | SVP,CFO | M.d | 33 | 6.95 | 0 | 5 | 46 | 15 | D | | | | | | | | | | | | | | |
12/21/07 15:31 | 12/21/07 | CVTX | Cv Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Spiegelman Daniel K | CA | O | SVP,CFO | S | -60 | 10.00 | 0 | -6 | -38 | 10 | D | | | | | | | | | | | | | | |
12/11/07 16:16 | 12/10/07 | CVTX | Cv Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Spiegelman Daniel K | CA | O | SVP,CFO | S | -80 | 10.03 | 0 | -8 | -39 | 13 | D | | | | | | | | | | | | | | |
1/18/07 18:47 | 1/17/07 | CVTX | Cv Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Spiegelman Daniel K | CA | O | SVP,CFO | S | -98 | 13.93 | 0 | -7 | -48 | 8 | D | | | | | | | | | | | | | | |
1/5/07 17:03 | 1/3/07 | CVTX | Cv Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Spiegelman Daniel K | CA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 13 | | 12 | D | | | | | | | | | | | | | | |
12/13/06 17:54 | 12/12/06 | CVTX | Cv Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Spiegelman Daniel K | CA | O | SVP,CFO | S.d | -39 | 12.92 | 0 | -3 | -47 | 3 | D | | | | | | | | | | | | | | |
12/7/06 17:41 | 12/5/06 | CVTX | Cv Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Spiegelman Daniel K | CA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 5 | 140 | 9 | D | | | | | | | | | | | | | | |
1/5/06 18:26 | 1/3/06 | CVTX | Cv Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Spiegelman Daniel K | CA | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 0 | 5 | 3 | B | | | | | | | | | | | | | | |
11/4/05 18:05 | 11/3/05 | CVTX | Cv Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Spiegelman Daniel K | CA | O | SVP,CFO | M.d | 245 | 9.24 | 0 | 27 | | 3 | D | | | | | | | | | | | | | | |
11/4/05 18:05 | 11/3/05 | CVTX | Cv Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Spiegelman Daniel K | CA | O | SVP,CFO | S.d | -668 | 25.21 | 0 | -27 | -89 | 3 | D | | | | | | | | | | | | | | |
8/30/05 13:32 | 8/26/05 | CVTX | Cv Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Spiegelman Daniel K | CA | O | SVP,CFO | S | -564 | 26.24 | 0 | -22 | -48 | 24 | M | | | | | | | | | | | | | | |
12/29/04 12:38 | 12/28/04 | CVTX | Cv Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Spiegelman Daniel K | CA | O | SVP,CFO | M.d | 9 | 9.00 | 0 | 1 | 5 | 23 | D | | | | | | | | | | | | | | |
12/20/04 14:09 | 12/16/04 | CVTX | Cv Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Spiegelman Daniel K | CA | O | SVP,CFO | M.d | 68 | 9.00 | 0 | 8 | 22 | 42 | D | | | | | | | | | | | | | | |
12/20/04 14:09 | 12/16/04 | CVTX | Cv Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Spiegelman Daniel K | CA | O | SVP,CFO | S.d | -179 | 23.86 | 0 | -8 | -15 | 42 | D | | | | | | | | | | | | | | |